Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03644368
Other study ID # RECHMPL18_0212
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2015
Est. completion date December 2018

Study information

Verified date July 2018
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To descride the clinical presentation, diagnosis, management and complications of children with a deep neck infection. A retrospective chart review was conducted at the Montpellier hospital in France. All children aged less than 18 years who had been admitted with a diagnosis of cervical phlegmon, tonsillar abscesses, retropharyngeal or parapharyngeal abscesses between January 2015 and December 2017 were included. The investigators collected the demographic, biological, radiological data and treatment received of the patients to the admision. The results of the bacteriological samples were collected. The investigators compared our results to those of the 10-year cohort. The investigators wish to compare the duration of hospitalization and the duration of the fever enter the group treated by alone antibiotic and the group treated by antibiotic and surgical drainage


Recruitment information / eligibility

Status Completed
Enrollment 83
Est. completion date December 2018
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 1 Month to 18 Years
Eligibility Inclusion criteria:

- under 18 years old

- hospitalized for acute pharyngeal infection ( cervical phlegmon, tonsillar abscesses, retropharyngeal or parapharyngeal abscesses)

Exclusion criteria:

- neck infection in the context of immune deficiency

- malignancy or post-traumatic disease

- others deep neck infections: angina, otitis, sinusitis, ethmoiditis, mastoiditis.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other duration of hospitalization Compare the duration of hospitalization enter the group treated by alone antibiotic and the group treated by antibiotic and surgical drainage. 1 day
Other duration of the fever Compare the duration of the fever enter the group treated by alone antibiotic and the group treated by antibiotic and surgical drainage. 1 day
Primary Clinical description of acute peripharyngeal suppuration Clinical description of acute peripharyngeal suppuration suppuration 1 day
Secondary Description of therapeutic management Description of therapeutic management : vaccinations, treatments received before hospitalization, treatments received during hospitalization 1 day
Secondary Description of bacteria in deep neck infections Description of bacteria in deep neck infections 1 day